Krishna Institute of Medical Sciences Limited
NSE:KIMS.NS
632 (INR) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,724 | 7,773 | 6,884 | 6,337.97 | 6,058.36 | 6,524.82 | 6,060.29 | 5,759.29 | 5,621.62 | 5,640.72 | 4,955.14 | 3,524.92 | 3,935.68 | 4,117.4 | 4,731.79 | 3,585.38 | 3,606.65 | 4,096.33 | 2,011.01 | 2,662.69 | 1,642.645 | 1,642.645 |
| Cost of Revenue
| 1,618 | 1,555 | 3,002 | 2,891.56 | 2,651.94 | 2,786.83 | 2,661.73 | 2,492.83 | 2,439.96 | 2,094.51 | 2,224.95 | 1,207.36 | 1,432.2 | 1,490.2 | 1,848.55 | 2,415.39 | 1,341.82 | 1,515.89 | 896.76 | 1,990.19 | 755.915 | 755.915 |
| Gross Profit
| 6,106 | 6,218 | 3,882 | 3,446.41 | 3,406.42 | 3,737.99 | 3,398.56 | 3,266.46 | 3,181.66 | 3,546.21 | 2,730.19 | 2,317.56 | 2,503.48 | 2,627.2 | 2,883.24 | 1,169.99 | 2,264.83 | 2,580.44 | 1,114.25 | 672.5 | 886.73 | 886.73 |
| Gross Profit Ratio
| 0.791 | 0.8 | 0.564 | 0.544 | 0.562 | 0.573 | 0.561 | 0.567 | 0.566 | 0.629 | 0.551 | 0.657 | 0.636 | 0.638 | 0.609 | 0.326 | 0.628 | 0.63 | 0.554 | 0.253 | 0.54 | 0.54 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 243.16 | 0 | 0 | 0 | 1,791.07 | 0 | 0 | 0 | 93.5 | 0 | 0 | 0 | 251.17 | 0 | 0 | 0 | 17.71 | 492.145 | 492.145 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 251.59 | 0 | 0 | 0 | 197.39 | 0 | 0 | 0 | 111.51 | 0 | 0 | 0 | 32.24 | 0 | 0 | 0 | 28.9 | 16.415 | 16.415 |
| SG&A
| 0 | 0 | 2,478 | 2,319.71 | 2,288.97 | 2,291.34 | 2,150.57 | 1,988.46 | 2,002.76 | 0 | 1,652.73 | 1,187.89 | 0 | 0 | 0 | 283.41 | 0 | -1,248.46 | 0 | 46.61 | 508.56 | 508.56 |
| Other Expenses
| 4,681 | 4,447 | 0 | 0 | 32.55 | 28.82 | 31.12 | 48.83 | 0 | 3,546.21 | 0 | 0 | 2,503.48 | 2,627.2 | 2,883.24 | 0 | 2,264.83 | 2,580.44 | 1,114.25 | 0 | 0 | 0 |
| Operating Expenses
| 4,681 | 4,447 | -390 | 2,319.71 | 2,288.97 | 5,121 | 3,721 | 1,988.46 | 3,514.58 | 3,546.21 | 3,024.36 | 1,195.56 | 2,503.48 | 2,627.2 | 2,883.24 | 2,248.45 | 2,264.83 | 1,331.98 | 1,114.25 | 46.61 | 670.575 | 670.575 |
| Operating Income
| 1,425 | 1,771 | 1,404 | 1,126.7 | 1,148.77 | 1,475.25 | 1,248 | 1,326.86 | 1,178.9 | 1,213.13 | 1,077.46 | 1,129.97 | 1,109.53 | 1,106.39 | 1,265.8 | 917.31 | 735.7 | 1,248.46 | 187.75 | 464.22 | 378.17 | 378.17 |
| Operating Income Ratio
| 0.184 | 0.228 | 0.204 | 0.178 | 0.19 | 0.226 | 0.206 | 0.23 | 0.21 | 0.215 | 0.217 | 0.321 | 0.282 | 0.269 | 0.268 | 0.256 | 0.204 | 0.305 | 0.093 | 0.174 | 0.23 | 0.23 |
| Total Other Income Expenses Net
| -79 | -149 | -133 | -126.76 | -123.77 | -89.1 | -62.21 | -54.15 | -50.73 | 161.53 | -3.91 | -61.79 | 13.93 | 25.19 | -20.49 | -107.11 | -90.52 | -53.75 | -47.69 | -89.22 | -234.81 | -234.81 |
| Income Before Tax
| 1,346 | 1,622 | 1,271 | 999.94 | 1,025 | 1,386.15 | 1,185.79 | 1,272.71 | 1,128.17 | 1,374.66 | 1,073.55 | 1,068.18 | 1,123.46 | 1,131.58 | 1,245.31 | 810.2 | 645.18 | 1,194.71 | 140.06 | 375 | 143.36 | 143.36 |
| Income Before Tax Ratio
| 0.174 | 0.209 | 0.185 | 0.158 | 0.169 | 0.212 | 0.196 | 0.221 | 0.201 | 0.244 | 0.217 | 0.303 | 0.285 | 0.275 | 0.263 | 0.226 | 0.179 | 0.292 | 0.07 | 0.141 | 0.087 | 0.087 |
| Income Tax Expense
| 421 | 415 | 319 | 285.02 | 258.99 | 373.21 | 319.08 | 285.96 | 309.9 | 313.98 | 281.1 | 234.94 | 281.59 | 289.04 | 325.01 | 223.99 | 167.39 | 293.16 | 50.82 | 97.6 | 50.085 | 50.085 |
| Net Income
| 887 | 1,074 | 866 | 654.73 | 718.44 | 920.16 | 808 | 932.72 | 759.8 | 971.14 | 699.58 | 806.88 | 811.75 | 817.17 | 891.05 | 578.02 | 487.91 | 834.75 | 111.27 | 286.52 | 89.045 | 89.045 |
| Net Income Ratio
| 0.115 | 0.138 | 0.126 | 0.103 | 0.119 | 0.141 | 0.133 | 0.162 | 0.135 | 0.172 | 0.141 | 0.229 | 0.206 | 0.198 | 0.188 | 0.161 | 0.135 | 0.204 | 0.055 | 0.108 | 0.054 | 0.054 |
| EPS
| 2.22 | 2.68 | 2.16 | 1.64 | 1.8 | 2.3 | 2.02 | 2.33 | 1.9 | 2.43 | 1.75 | 1.78 | 2.03 | 2.07 | 2.3 | 1.52 | 1.31 | 2.2 | 0.29 | 0.76 | 0.25 | 0.25 |
| EPS Diluted
| 2.22 | 2.68 | 2.16 | 1.64 | 1.8 | 2.3 | 2.02 | 2.33 | 1.9 | 2.43 | 1.75 | 1.78 | 2.03 | 2.07 | 2.3 | 1.49 | 1.29 | 2.15 | 0.29 | 0.76 | 0.25 | 0.25 |
| EBITDA
| 2,050 | 2,231 | 1,840 | 1,627.77 | 1,503 | 1,801.54 | 1,601.76 | 1,681.17 | 1,576.33 | 1,764.65 | 1,424.98 | 1,292.02 | 1,341.19 | 1,341.85 | 1,479.41 | 1,018.84 | 931.16 | 1,427.8 | 400.86 | 615.54 | 312.695 | 312.695 |
| EBITDA Ratio
| 0.265 | 0.287 | 0.267 | 0.257 | 0.248 | 0.276 | 0.264 | 0.292 | 0.28 | 0.313 | 0.288 | 0.367 | 0.341 | 0.326 | 0.313 | 0.284 | 0.258 | 0.349 | 0.199 | 0.231 | 0.19 | 0.19 |